Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23a4e0c875bf1ac2b8a3b76517de6c7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a46b73f34deb4f8ab0c44fb81ff17f0b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb91aa332d6a804f5918a64eb9fa4d13 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0362 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2207-12 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-39 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate |
2018-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94c5d31ae5a18a9cd6c4e43e2b2aa91f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c7f0e53c0a9bd24f99f69b19cde26dc |
publicationDate |
2020-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3658162-A1 |
titleOfInvention |
Collagen encapsulation of insulin-producing cells |
abstract |
The present invention provides compositions comprising collagen and insulin-producing cells. This invention also relates to methods of making such compositions comprising collagen and insulin producing cells. The invention also relates to methods of regulating or decreasing blood glucose levels and treating metabolic disorders in mammals, including type 1 diabetes, with such compositions. The invention further relates to methods for prolonging the viability and function of insulin-producing cells in vitro or during transport. |
priorityDate |
2017-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |